PEDIATRICS Vol. 64 No. 5 November 1979, pp. 795-802
This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stites, D. P.
Right arrow Articles by Pavia, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stites, D. P.
Right arrow Articles by Pavia, C. S.

Ontogeny of Human T Cells

Daniel P. Stites MD1 and Charles S. Pavia PhD1

1 Departments of Laboratory Medicine and Medicine, University of California, San Francisco

Current knowledge of human T cell ontogeny is reviewed in terms of appearance of T cells in central and peripheral lymphoid organs, maturation of T cell markers, and development of immune functions. Extrapolation of growth curves derived from cell counts from fetal thymus, spleen, and bone marrow indicates the appearance of lymphocytes at 3.5 weeks gestation. Erosette-forming cells are present in thyrnus at 11 weeks and in peripheral organs 15 to 16 weeks gestation. beta-2-Microglobulin is associated with all lymphoid cells by 13 weeks gestation. Lymphocyte responses to the T cell mitogen phytohemagglutinin (PHA) are first detected in thymus at 10 weeks and in spleen and blood 3 to 4 weeks later. Allogeneic responses in mixed lymphocyte reactions develop at about 7.5 weeks in fetal liver and later in thymus and peripheral organs. Lymphocytotoxicity for xenogeneic cells is a property of bone marrow cells and not thymocytes. Several aspects of development of a suppressor T cell in human neonates is discussed and related to similar findings in the mouse. These studies indicate a relatively high degree of maturation of human T cells during fetal life.




This article has been cited by other articles:


Home page
 BloodHome page
E. T. Durkin, K. A. Jones, D. Rajesh, and A. F. Shaaban
Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras
Blood, December 15, 2008; 112(13): 5245 - 5253.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Darrasse-Jeze, G. Marodon, B. L. Salomon, M. Catala, and D. Klatzmann
Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses
Blood, June 15, 2005; 105(12): 4715 - 4721.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
N A Gillett and C Chan
Applications of immunohistochemistry in the evaluation of immunosuppressive agents
Human and Experimental Toxicology, April 1, 2000; 19(4): 251 - 254.
[Abstract] [PDF]